Literature DB >> 7672677

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.

J Labenz1, M Stolte, A L Blum, I Jorias, F Leverkus, M Sollböhmer, J Bertrams, G Börsch.   

Abstract

Omeprazole plus amoxicillin cures Helicobacter pylori infection. The hypothesis was tested that low acidity is a predictor of outcome. Fifty patients with relapsing or complicated, or both H pylori positive duodenal (n = 25) or gastric ulcer (n = 25) were randomly treated with either omeprazole 20 mg twice daily plus amoxicillin 1 g twice daily or with omeprazole 40 mg twice daily plus amoxicillin 1 g twice daily over two weeks. After one week of combined treatment, a 24 hour gastric pH measurement was performed in all patients. H pylori cure rate was 67%. Patients who later turned out to be cured had higher pH values during night time and after meals (p < 0.05). In an explorative analysis drug compliance, smoking, location of the ulcer (duodenum versus stomach), age, and grade of body gastritis were additional predictors of the outcome. Smoking (p = 0.006), compliance (p = 0.037), duodenal ulcer disease (p = 0.065), and young age (p = 0.021) were related to high acidity. In conclusion, the success of eradication treatment with omeprazole and amoxicillin in ulcer patients infected with H pylori depends on intragastric pH. Drug compliance, smoking habits, location of ulcer, age, and activity of body gastritis are other predictors and in part related to intragastric acidity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672677      PMCID: PMC1382765          DOI: 10.1136/gut.37.1.39

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Clarithromycin and omeprazole for Helicobacter pylori.

Authors:  R P Logan; P A Gummett; B T Hegarty; M M Walker; J H Baron; J J Misiewicz
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

2.  Omeprazole, campylobacter pylori, and duodenal ulcer.

Authors:  P Mainguet; M Delmée; J C Debongnie
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

3.  Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.

Authors:  M L Grayson; G M Eliopoulos; M J Ferraro; R C Moellering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

4.  pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism.

Authors:  R H Hunt
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

5.  Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.

Authors:  E Verdu; F Viani; D Armstrong; R Fraser; H H Siegrist; B Pignatelli; J P Idström; C Cederberg; A L Blum; M Fried
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

6.  [Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine].

Authors:  G Zala; R Flury; J Wüst; C Meyenberger; R Ammann; H P Wirth
Journal:  Schweiz Med Wochenschr       Date:  1994-08-09

7.  [24-hour gastric pH profile with 2 x 20 mg and 2 x 40 mg omeprazole in patients with Helicobacter pylori-associated gastroduodenal ulcer disease].

Authors:  J Labenz; I Jorias; M Sollböhmer; U Peitz; M Stolte; G Börsch
Journal:  Z Gastroenterol       Date:  1994-08       Impact factor: 2.000

8.  Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori.

Authors:  J Labenz; E Gyenes; G H Rühl; G Börsch
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

Review 9.  Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.

Authors:  G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1994-08       Impact factor: 8.171

10.  Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success.

Authors:  J Labenz; F Leverkus; G Börsch
Journal:  Scand J Gastroenterol       Date:  1994-12       Impact factor: 2.423

View more
  25 in total

Review 1.  What is potent acid inhibition, and how can it be achieved?

Authors:  Xavier Calvet; Fernando Gomollón
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Influence of smoking and CYP2C19 genotypes on H. pylori eradication success.

Authors:  T Suzuki; K Matsuo; A Sawaki; K Wakai; K Hirose; H Ito; T Saito; T Nakamura; K Yamao; N Hamajima; K Tajima
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

3.  Twice-daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy.

Authors:  G Manes; O Pieramico; F Perri; D Vaira; N Giardullo; M Romano; G Nardone; A Balzano
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  Loose ends in the eradication of Helicobacter pylori infection.

Authors:  Armando Peixoto; Marco Silva; Rui Gaspar; Rui Morais; Rosa Ramalho; Guilherme Macedo; João Santos-Antunes
Journal:  J Transl Int Med       Date:  2016-12-30

5.  Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.

Authors:  Tomohiko Shimatani; Masaki Inoue; Tomoko Kuroiwa; Jing Xu; Susumu Tazuma; Yoko Horikawa; Masuo Nakamura
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

6.  CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability.

Authors:  T Kita; Y Tanigawara; N Aoyama; T Hohda; Y Saijoh; F Komada; T Sakaeda; K Okumura; T Sakai; M Kasuga
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

Review 7.  Potent gastric acid inhibition in Helicobacter pylori eradication.

Authors:  Javier P Gisbert
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

Authors:  P Moayyedi; D M Chalmers; A T Axon
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

9.  Helicobacter pylori therapy: Present and future.

Authors:  Vincenzo De Francesco; Enzo Ierardi; Cesare Hassan; Angelo Zullo
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

10.  The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin.

Authors:  E A Marcus; N Inatomi; G T Nagami; G Sachs; D R Scott
Journal:  Aliment Pharmacol Ther       Date:  2012-09-25       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.